The Role of C-Reactive Protein Activation of Nuclear Factor Kappa-B in the Pathogenesis of Unstable Angina**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 2, 2007, Pages 195-197

  Jialal, Ishwarlal ^a   Devaraj, Sridevi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD32 ANTIGEN; CD64 ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P50; STAT3 PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; CYTOKINE RELEASE; EDITORIAL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SMOOTH MUSCLE FIBER; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; C-REACTIVE PROTEIN; CHEMOKINES; CHEMOTAXIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; MALE; NF-KAPPA B; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33845988732     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.10.018     Document Type: Editorial

References (18)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-kappaB: its role in health and disease. J Mol Med 82 (2004) 434-448
3. Verma S., Devaraj S., and Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit?. C-reactive protein promotes atherothrombosis. Circulation 113 (2006) 2135-2150
4. Liuzzo G., Santamaria M., Biasucci L.M., et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein: evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 49 (2007) 185-194
5. Devaraj S., Kumaresan P.R., and Jialal I. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol 36 (2004) 405-410
6. Nakakuki T., Ito M., Iwasaki H., et al. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25 (2005) 2088-2093
7. Kawanami D., Maemura K., Takeda N., et al. C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells. Atherosclerosis 185 (2006) 39-46
8. Liang Y.J., Shyu K.G., Wang B.W., and Lai L.P. C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J Mol Cell Cardiol 40 (2006) 412-420
9. Devaraj S., Davis B., Simon S.I., and Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fc gamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol 291 (2006) H1170-H1176
10. Hattori Y., Matsumura M., and Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58 (2003) 186-195
11. Cirillo P., Golino P., Calabro P., et al. C-Reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68 (2005) 47-55
12. Jialal I., Stein D., Balis D., Grundy S.M., et al. Effect of HMG-CoA reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103 (2001) 1933-1935
13. Liao J.K., and Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45 (2005) 89-118
14. Ridker P.M., Cannon C.P., Morrow D., et al., Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
15. Jialal I., Devaraj S., and Singh U. Sources of CRP in atherosclerotic lesions. Am J Pathol 168 (2006) 1054-1055
16. Sattler K.J.E., Woodrum J.E., Galili O., et al. Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor κB activation and C-reactive protein expression in human carotid artery plaques. Stroke 36 (2005) 14-20
17. Toniatti C., Arcone R., Majello B., Ganter U., Arpaia G., and Ciliberto G. Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer. Mol Biol Med 7 (1990) 199-212
18. Jialal I., Devaraj S., and Singh U. CRP and the vascular endothelium. J Am Coll Cardiol 47 (2006) 1379-1381